title: Re: Prediction of the fetal Kell blood group reduces aggressive interventions.
authors.forename: F
authors.initials: F
authors.lastname: Araújo
authors.forename: F
authors.initials: F
authors.lastname: Monteiro
authors.forename: C
authors.initials: C
authors.lastname: Pereira
authors.forename: J
authors.initials: J
authors.lastname: Duran
authors.forename: H
authors.initials: H
authors.lastname: Nascimento
authors.forename: L
authors.initials: L
authors.lastname: Lima
authors.forename: A
authors.initials: A
authors.lastname: Cunha
authors.forename: J
authors.initials: J
authors.lastname: Storry
authors.forename: J
authors.initials: J
authors.lastname: Guimarães
mesh_terms: D000328:Adult; D004899:Erythroblastosis, Fetal / Q000097:blood* / Q000175:diagnosis*; D005260:Female; D005312:Fetal Blood / Q000166:cytology*; D005865:Gestational Age; D006403:Hematologic Tests; D006801:Humans; D007626:Kell Blood-Group System / Q000276:immunology*; D008423:Maternal Age; D016133:Polymerase Chain Reaction / Q000379:methods*; D011237:Predictive Value of Tests; D011247:Pregnancy; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
chemical_list: D007626:Kell Blood-Group System